<<
>>

: . . .. - , .. , .. . .: , 2000. .., .., - .. . - .
, . 1991; 36(2): 27-29. .., .. . tuberculosis: . Consilium Medicum 2001; 3(12): 595-602. . . ., - (USP DI), . . . 3. . .: , 1998. .., .. . WWW. rlsnet.ru/articles_447.htm. .. : . Consilium Medicum 2006; 8(1). . . .. , .. ,


.. . : , 2007: 88-94. . . : . , . , - . 2001; 3(2): 111-132. . . - : .... - . . , 2004. . . .. , .. . .: , 2003: 102 111,495-513. .., .. . . , . 1998; 61(3): 50-53. .., .., .., .. . , . 1999; 44(2): 29-32. .., .., .. . . . . 1991; 7: 43-46. .., .., .. . Pseudomonas aeruginosa, . , . , . 2003; 5(1): 3545. .. - . . . . . 1997; 5(21): 1382-1391. .., .. . .: , 2003. .., .. . Consilium Medicum 2001; 9(1): 30-34. Anderson R.A. The effect of antibiotics and of drug associations including antibiotics on the immunodefense system.
In: Useful and harmful interactions of antibiotics. Ed. by M. Neumann. Boca Raton: CRC Press, 1985: 185-203. Au L.F., Othman F., Mustaffa R. et al. Cytotoxicity and scanning electron microscopy study of gentamycin-coated HA effect on biofilm. Med. J. Malaysia 2008; 63: 16-17. Baker-Austin C., McArthur J.V., Tuckfield R.C. et al. Antibiotic resistance in the shellfish pathogen Vibrio parahaemolyticus isolated from the coastal water and sediment of Georgia and South Carolina, USA. J. Food Prot. 2008; 71; 2552-2558. BarzaM., loannidis J.P., Cappelleri J.C., Lau J. Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ 1996; 312: 338-345. Bjarnsholt T., Jensen P.Q., Burmolle M. etal.
Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiology 2005; 151: 373-383. Borkow G., Vijayabaskar V., Lara Ft.Ft. etal. Structure-activity relationship of neomycin, paromomycin, and neamine-arginine conjugates, targeting HIV-1 gpl20-CXCR4 binding step. Antiviral. Res. 2003; 60: 181-192. Brom C., Brom J., Konig W. Neomycin induces stimulatory and inhibitory effects on leukotriene generation, guanine triphosphatase activity, and actin polymerization within human neutrophils. Immunology 1992; 75: 150-156. Cabrera C., Gutierrez A., Blanco J. et al.
Anti-human immunodeficiency virus activity of novel aminoglycoside-arginine conjugates at early stages of infection. AIDS Res. Hum. Retrovir. 2000; 16: 627-634. Contopoulos-loannidis D.G., Giotis N.. Bal- iatsa D.V., loannidis J.P.A. Extended-Interval Aminoglycoside Administration for Children: A Meta-analysis. Pediatrics 2004; 114: 111-118. Dal Negro R., Micheletto C., Tognella S. et
al. Tobramycin Nebulizer Solution in severe COPD patients colonized with Pseudomonas

aeruginosa: effects on bronchial inflammation. Adv. Ther. 2008; 25: 1019-1030. Daneshvar H., Hagan P., Phillips R.S. Leish- mania mexicana H-line attenuated under pressure of gentamicin, potentiates a Thl response and control of cutaneous leishmaniasis in BALB/c mice. Parasite Immunol. 2003; 25: 589-596. Deguchi K., KoguchiM., Suzuki Y. ef al. Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 3. The results against Pseudomonas aeruginosa. Jpn. J. Antibiot. 1996; 49: 509-516. El'Garch F., Jeannot K., Hocquef D. efal. Cumulative Effects of Several Nonenzymatic Mechanisms on the Resistance of Pseudomonas aeruginosa to Aminoglycosides. Antimi- crob. Agents Chemother. 2007; 51: 1016-1021. Errecalde C.A., Priefo G.F., Trotfi N. ef al. Pharmacokinetics of amikacin after single intravenous and intramuscular administration in calves. J. Vet. Pharmacol. Ther. 2001; 24: 137-139. Ferreira T. Disseminated MAC: current treatment strategies. STEP Perspect. 1995; 7:15-16. Gutschik E. Experimental endocarditis in rabbits. 6. Results of long-term combined therapy of Streptococcus faecalis endocarditis with penicillin and streptomycin. Acta Pathol. Microbiol. Immunol. Scand. [B] 1982; 90: 37-47. Hazama S., Kikuchi ., Kanno M. Influence of aminoglycoside antibiotics, streptomycin and kanamycin on histamine secretion in mast cells. J. Toxicol. Sci. 1992; 17: 1-11. Hafala R., Dinh T., Cook D.J. Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis. Ann. Intern. Med. 1996; 124: 717-725. Hafala R., Dinh T.T., Cook D.J. Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review. Clin. Infect. Dis. 1997; 24: 810-815. Hoffman L.R., D'Argenio D.A., MacCoss M.J. efal. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 2005; 436: 1171-1175. Ibrahim M.S., Maged Z.A., Haron A. ef al.
Antibiotics and immunity: effects of antibiotics on mitogen responsiveness of lymphocytes and interleukin-2 production. Chemi- oterapia 1988; 7: 369-372. Jana S., Deb J.K. Molecular targets for design of novel inhibitors to circumvent aminoglycoside resistance. Curr. Drug Targets 2005; 6: 353-361. Jana S., Deb J.K. Molecular understanding of aminoglycoside action and resistance. Appl. Microbiol. Biotechnol. 2006; 70: 140150. Labro M.-T. Interference of Antibacterial Agents with Phagocyte Functions: Im- munomodulation or Immuno-Fairy Tales? Clin. Microbiol. Rev. 2000; 13: 615-650. Leibovici L., Vidal L., Paul M. Aminoglycoside drugs in clinical practice: an evidence- based approach. J. Antimicrob. Chemother. 2009; 63: 246-251. Lejbkowicz F., Belavsky L., Kudinsky R., Gery R. Bacteraemia and sinusitis due to Flavimonas oryzihabitans infection. Scand. J. Infect. Dis. 2003; 35: 411-414. Lenoir G., Anfypkin Y.G., Miano A. ef al. Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Paediatr. Drugs 2007; 9: 11-20. MayerK.H. Review of epidemic aminoglycoside resistance worldwide. Am. J. Med. 1986; 80: 56-64. Maldonado P.D., Barrera D., Medina-Cam- pos O.N. ef al. Aged garlic extract attenuates gentamicin induced renal damage and oxidative stress in rats. Life Sci. 2003; 73: 2543-2556. Mandell L.A. Effects of antimicrobial and antineoplastic drugs on the phagocytic and microbicidal function of the polymorphonuclear leukocyte. Rev. Infect. Dis. 1982; 4: 683-697. Mendez-Tovar L.J., Serrano-Jaen L., Al- meida-Arvizu V.M. Combined cefotaxime and amikacin for immunomodulation in the treatment of actinomycetoma resistant to conventional treatment. Gac. Med. Mex. 1999; 135: 517-521. Miyafa ., Shinohara M. Effect of antibiotics on rat leukocyte function. J. Osaka Dent. Univ. 1998; 32: 9-15. Nubile G., Tresca E., Di Profio E. ef at. Effects of aminoglycosides on T and lymphocyte populations: in vitro study. Quad. Scla- vo. Diagn. 1985; 21: 130-134. Oyama N., Sudo N., Sogawa H., Kubo C. Antibiotic use during infancy promotes a shift in the T(H)1/T(H)2 balance toward T(H)2-dominant immunity in mice. J. Allergy Clin. Immunol. 2001; 107: 153-159. Pedraza-Chaverri J., Maldonado P.D., A4e- dina-Campos O.N. et al. Garlic ameliorates gentamicin nephrotoxicity: relation to antioxidant enzymes. Free Radio. Biol. Med. 2000; 29: 602-611. Posfay-Barbe K.M., Wald E.R. Listeriosis. Semin. Fetal. Neonatal. Med. 2009; 14: 228233. Qian K., Wang S. Infections caused by Fla- vimonas oryzihabitans. Chin. Med. J. (Engl.) 2001; 114: 394-398. Rao S.C., Ahmed M., Hagan R. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. Cochrane Database Syst. Rev. 2006; 1: CD005091. Rasfogi N., Labrousse V., Goh K.S. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. Curr. Microbiol. 1996; 33: 167 175. Roberts J. A., LipmanJ. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit. Care Med. 2009; 37: 840-851. Roszkowski K., Beuth J., H.L. et al. Influence of 12 antibiotics on antitumor immunity in BALB/c-mice. Zentralbl. Bakteriol. 1992; 276: 280-287. Roszkowski W., KoH.L., Roszkowski K. etal.
Antibiotics and immunomodulation: effects of cefotaxime, amikacin, mezlocillin, piperacillin and clindamycin. Med. Microbiol. Immunol. 1985; 173: 279-289. Schurek K.N., Marr A.K., Taylor P.K. et al. Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2008; 52: 4213-4219. Shea J.J., Norris C.H. Streptomycin perfusion of the labyrinth. Acta Otolaryngol. Sup- pi. 1991; 485: 123-130. Setny P., Trylska J. Search for Novel Aminoglycosides by Combining Fragment-Based Virtual Screening and 3D-QSAR Scoring. J. Chem. Inf. Model. 2009; 49: 390-400. Smyth A.R., Tan K.H. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis. Cochrane Database Syst. Rev. 2006; 3: CD002009. Soliman K.M., Abdul-Hamid M., Othman A.I. Effect of carnosine on gentamicin-induced nephrotoxicity. Med. Sci. Monit. 2007; 13: 73-83. Sudo N., Yu X.N., Aiba Y. et al. An oral introduction of intestinal bacteria prevents the development of a long-term Th2-skewed immunological memory induced by neonatal antibiotic treatment in mice. Clin. Exp. Allergy 2002; 32: 1112-1116. Umeki S. Anti-inflammatory action of gentamycin through inhibitory effect on neutrophil NADPH oxidase activity. Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 1995; 110: 817-821. Venezio F.R., DiVincenzo C.A. Effects of aminoglycoside antibiotics on polymorphonuclear leukocyte function in vivo. Antimicrob. Agents Chemother. 1985; 27: 712-714. Villa M.L., Rappocciolo G., Piazza P., Cleri- ci E. The interference of antibiotics with antigen-specific antibody responses in man. Int. J. Immunopharmacol. 1986; 8: 805-809. Vosbeck K., James P.R., Zimmermann W. Antibiotic action on phagocytosed bacteria measured by a new method for determining viable bacteria. Antimicrob. Agents Chemother. 1984; 25: 735-741.

<< | >>
: .. , .. , .. . 2012. 2012

:

- - - -
- - - - - - - - - - - - - -